Experience
Innovacell AG
University of Pittsburgh
Represented Innovacell in opposition related to muscle derived cells.
Innovacell AG v. University of Pittsburgh, T 0527/17, EPO
*Matter handled prior to joining Finnegan
Innovacell Biotechnologie AG v. University of Pittsburgh*
Innovacell Biotechnologie AG
Innovacell Biotechnologie AG v. University of Pittsburgh*
Innovacell Biotechnologie AG
Academisch Ziekenhuis Leiden v. University of Western Australia
University of Western Australia
Abbott
GlaxoSmithKline
Hyundai Electronics v. Siemens AG
Hyundai Electronics
Finnegan client BTG prevails in EPO opposition proceedings in the field of vein sclerotherapy
BTG International, Ltd.
Bayerische Motoren Werke Aktiengesellschaft
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.